Renovascular hypertension in children
CVIR Endovascular volume 4, Article number: 10 (2021)
Paediatric hypertension, defined as systolic blood pressure > 95th percentile for age, sex and height is often incidentally diagnosed. Renovascular hypertension (RVH) is responsible for 5–25% of hypertension in children. Renal artery stenosis and middle aortic syndrome can both can be associated with various conditions such as fibromuscular dysplasia, Williams syndrome & Neurofibromatosis type 1. This paper discusses the approaches to diagnosis and interventional management and outcomes of renovascular hypertension in children. Angiography is considered the gold standard in establishing the diagnosis of renovascular disease in children. Angioplasty is beneficial in the majority of patients and generally repeated angioplasty is considered more appropriate than stenting. Surgical options should first be considered before placing a stent unless there is an emergent requirement. Given the established safety and success of endovascular intervention, at most institutions it remains the preferred treatment option.
Paediatric hypertension is defined as systolic blood pressure > 95th percentile for age, sex and height (National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents 2004). Despite guidelines from USA and Europe strongly recommending regular blood pressure screening in children (Tullus 2018), blood pressure in children is not often measured therefore, hypertension is usually an incidental diagnosis in childhood. Early identification and management of hypertension can help reduce the risk of long term cardiac and cerebrovascular events and renal impairment (Bartosh and Aronson 1999; Zhu et al. 2014).
RVH is hypertension resulting in alteration of the renin-angiotensin mechanism secondary to a lesion reducing blood flow to part or all of one or both kidneys (Lobeck et al. 2018). RVH is responsible for 5–25% of hypertension in children and is potentially amenable to treatment for the purposes of control and in many cases cure (Zhu et al. 2014; Kurian et al. 2013; Meyers et al. 2014; Tullus et al. 2008; Srinivasan et al. 2011). This paper discusses the approaches to diagnosis and interventional management and outcomes of renovascular hypertension in children.
RVH can be caused by numerous pathologies both syndromic and non-syndromic. Renal artery stenosis (RAS) and middle aortic syndrome (MAS) can both be associated with various conditions such as fibromuscular dysplasia (FMD), Williams syndrome, Neurofibromatosis type 1, tuberous sclerosis and vasculitidies (Takayasu aorto-arteritis arteritis, Kawasaki disease, polyarteritis nodosa). RVH can also occur as a consequence of radiation vasculopathy, thrombosis and transplant renal artery stenosis. RAS and MAS can occur in many cases as an isolated entity (Lobeck et al. 2018; Roebuck 2008; Sethna et al. 2008).
The First International Consensus on the diagnosis and management of fibromuscular dysplasia defined FMD as “a non-atherosclerotic arterial disease that is characterized by abnormal cellular proliferation and distorted architecture of the arterial wall” (Gornik et al. 2019). The consensus document states that FMD primarily manifests as beaded (multifocal) or focal lesions in medium or small-sized arteries, although can include arterial dissection, aneurysm, and tortuosity (Gornik et al. 2019). The prevalence and manifestation of FMD in children is presently unknown, and although previously thought to be a rare disease, research emerging from patient registries in North America and Europe challenges this notion (Louis et al. 2018). Non-syndromic FMD is thought to be the most common cause of renovascular hypertension in children (Meyers et al. 2014; Tullus et al. 2010). Unifocal FMD is more common than the multifocal variant (Louis et al. 2018). The rate of observance of the classical angiographic appearance of multifocal FMD, the “string of beads” sign in children is unknown (Lobeck et al. 2018) and in our experience it is not often seen. However, in children, histological confirmation is very rarely obtained therefore the diagnosis is usually made by excluding other known causes of renovascular disease such as Takayasu’s arteritis (TA) and neurofibromatosis type 1 (Tullus et al. 2010).
TA is vasculitis involving large arteries which mainly affects young women, but can affect children (Tullus and Roebuck 2018; Forsey et al. 2011; Brunner et al. 2010). It can be a challenging diagnosis to make. There is only one mandatory criteria to make a diagnosis of TA in children, proposed jointly by the European League Against Rheumatism and The Pediatric Rheumatological Society and Pediatric Rheumatology International Trials Organization which is ‘angiographic abnormality not caused by FMD or similar disease’ (Arend et al. 1990; Ozen et al. 2010). TA usually presents generalized symptoms including malaise and weight loss, however around 50% present in a silent “burn out” phase making it appear identical to FMD and further adding to the diagnostic challenge (Tullus and Roebuck 2018).
Besides FMD, neurofibromatosis is the most common cause for renal artery stenosis in children in western countries (Srinivasan et al. 2011). NF1 is a neurogenetic disorder transmitted as an autosomal dominant trait with classic manifestations including café-au-lait macules, skinfold freckling, neurofibromas, brain tumors, iris hamartomas, and characteristic bony lesions. NF1-associated vasculopathies and renovascular hypertension are a little publicized but important manifestation and include abdominal aortic stenosis and osteal and non-osteal renal artery stenosis (Lie 1998).
Williams syndrome is a multisystem disorder with cardiovascular abnormalities, due to elastin deficiency, being the main cause of morbidity and mortality (Collins 2018).
Renal artery stenosis and middle aortic syndrome
RVH can be caused by an isolated renal artery stenosis (RAS) and/or middle aortic syndrome (MAS). RAS can be uni- or bilateral and has been reported to be bilateral in 24–78% in paediatric series (Lobeck et al. 2018; Tullus et al. 2008). When RAS are bilateral there are often concomitant aortic and other visceral vessel abnormalities (Lobeck et al. 2018). Focal arterial stenoses are most common in children (Vo et al. 2006). Diffuse stenoses are more likely when there is extra-renal disease, syndromes or vasculitidies (Lobeck et al. 2018; Vo et al. 2006). RAS lesions have been reported throughout the renovascular tree, with approximately 25% in the main renal arteries, 50% in 2nd order branches, 12.5% in more distal ‘parenchymal’ branches, and 12.5% in accessory renal arteries (Srinivasan et al. 2011; Vo et al. 2006).
Middle aortic syndrome (MAS) is a clinical condition generated by segmental narrowing of the abdominal or distal descending thoracic aorta (Lobeck et al. 2018; Delis and Gloviczki 2005). Most MAS are idiopathic (64%) with pathogenesis being largely speculative (Rumman et al. 2015). Events occurring around day 25 of fetal development when the two embryonic dorsal aortas fuse and lose their intervening wall to form a single vessel have been hypothesized to be the cause of many cases of MAS (Stanley et al. 2008). Concomitant RAS is seen in around 60% of children with mid aortic syndrome (Rumman et al. 2015). MAS is also associated with intestinal, iliac, carotid, cerebral and brachial arterial stenoses (Zhu et al. 2014; Tullus et al. 2008; Sethna et al. 2008; Rumman et al. 2015; Shroff et al. 2006; Kari et al. 2015; Stanley et al. 2006; Tyagi et al. 1997; Tummolo et al. 2009; Trautmann et al. 2017). Srinivasan et al. (2011) demonstrated in a study of 68 angiograms in children with renovascular hypertension that MAS is most commonly associated with NF1.
Diagnosis of Renovascular hypertension in children
A renovascular cause for hypertension is suggested by ultrasound when a stenosis is directly visualized, a parvus et tardus waveform pattern is seen or there are pathologic age-dependent flow parameters (peak systolic flow greater than 180 or 200 cm/s, acceleration time > 80 ms, renal artery to aortic flow velocity ratio > 3, and difference in resistive index more than 0.05) (Trautmann et al. 2017; Conkbayir et al. 2003; Brun et al. 1997; Krumme et al. 1996). Some authors also consider a significant difference in kidney length (≥1 cm) as an indirect sign of RAS (Trautmann et al. 2017).
Ease and ability to perform ultrasound repeatedly makes this modality the most useful and widely performed baseline investigation. Additionally, it can exclude non-vascular causes for hypertension (such as neuroblastoma or pheochromocytoma) and show discrepant renal lengths and other renal pathologies. Sensitivity and specificity for the detection of renal artery stenosis is thought to be lower than in adult patients (Trautmann et al. 2017), with reported sensitivity for Doppler US of 65–88% and specificity of 83–99% (Trautmann et al. 2017; Brun et al. 1997; Kchouk et al. 1997; Chhadia et al. 2013; Dillman et al. 2017; Castelli et al. 2014). Ultrasound performs best in older children and for detection of aortic stenosis (Roebuck 2008; Dillman et al. 2017). For segmental and subsegmental stenoses, involvement of multiple renal arteries and early branching of the main renal artery ultrasound performs poorly (Dillman et al. 2017).
Computed tomographic and magnetic resonance angiography
Computed tomographic angiography (CTA) and magnetic resonance angiography (MRA) are suggestive of a renovascular cause for hypertension when one or more stenoses are visualized as a reduction of the intraluminal diameter (Fig. 1) or if there is the presence of collateral vessels (Trautmann et al. 2017). Similar to ultrasound, in children, CTA and MRA are thought to be adequate for diseases of the aorta but for smaller vessels, especially intraparenchymal branches and in smaller children they are limited (Kurian et al. 2013; Tullus et al. 2008; Louis et al. 2018; Agrawal et al. 2018). In a study evaluating the accuracy of Doppler ultrasound, MRA, and CTA compared to angiography in 127 patients, MRA and CTA were performed in 39 and 34 children, respectively. CTA performed slightly better than MRA with sensitivities of 88% versus 80% and specificity of 81% versus 63% (Trautmann et al. 2017). Trautmann et al. found in their cohort, that CTA missed five cases of renovascular disease, all stenoses were in the main renal artery with additional stenosis in one of the branch renal arteries in one case (Trautmann et al. 2017). MRA missed 10 cases of renovascular disease including stenosis of the main renal artery in six cases, main branch artery in two cases and a segmental artery in two cases (Trautmann et al. 2017). The largest drawback with Truatmann et al.’s (2017) study is that it based on retrospective data using results obtained in many different pediatric radiology departments with variable and possibly non-optimized techniques.
Children who are thought to have a high probability of renovascular disease, for example those with normal body mass index, no family history, elevated renin, hypertension requiring multiple medications should undergo angiography with a view to endovascular treatment regardless of findings of non-invasive imaging (Fig. 1) (Tullus et al. 2008; Louis et al. 2018; Trautmann et al. 2017; Tullus 2011). This is because, in children, angiography is considered the gold standard in establishing the diagnosis of renovascular disease with no non-invasive technique considered capable of excluding renovascular disease (Tullus et al. 2008; Roebuck 2008; Louis et al. 2018; Tullus et al. 2010; Vo et al. 2006; Srinivasan et al. 2010). Louis et al. (2018) found that 28% of vascular lesions in children with hypertension were only detected by angiography. Using the criteria for angiography of poor blood pressure control on two or more medications an abnormality will be seen approximately 40% of the time (Tullus et al. 2008; Vo et al. 2006; Shahdadpuri et al. 2000).
Angiography allows only visualization of the vessel lumen. High resolution intravascular imaging techniques such as intra-vascular ultrasound (IVUS) (Fig. 2) and optical coherence tomography (OCT) have not been validated in renovascular intervention in children however they may help identify the early arterial wall changes, vessel wall thickness, degree of stenosis, evaluate aneurysmal walls and the results of angioplasty and/or stenting. These techniques have been shown be helpful for directing appropriate stent sizing and identifying acute complications such as dissection and stent malapposition with resultant improved clinical outcomes in adult renal artery and coronary intervention (Maehara et al. 2017; Mizutani et al. 2015; Vijayvergiya et al. 2019; Onoue et al. 2011).
Contrast US emerging role
Contrast enhanced US (CEUS) may play a role in evaluating renal perfusion pre and post angioplasty and may also be used as a modality for follow up. Renal CEUS can provide imaging analysis of time to parenchymal perfusion by imaging the main renal artery and branches at the hilum and identify any parenchymal perfusion defects (Fig. 3).
There has been growing interest recently in color-coded quantitative digital subtraction angiography (qDSA) (so called ‘perfusion imaging’). Current commercially available angiography quantification postprocessing software, such as syngo iFlow (Siemens Healthi- neers, Erlangen, Germany) and AngioViz (GE Healthcare, Chicago, Illinois) are limited by variability in flow, vessel size, amount of contrast injected, and frame rate (Patel et al. 2019). Despite this, qDSA has been reported useful in paediatric neurovascular intervention (Ma et al. 2019). At present although some centres find it a useful adjunct in renovascular intervention, its role it yet to be established (Fig. 4).
Renal vein renin sampling
Renal vein renin sampling has been reported to be useful in children (McLaren and Roebuck 2003; Goonasekera et al. 2002). Angiographic abnormalities are often bilateral or involve small intra-renal branches. Renal vein renin sampling can lateralize and even localize an ischemic focus which is causing hypertension and help direct selective treatment (Teigen et al. 1992). Renal vein renin samples are usually taken from the infra renal IVC, each renal vein and from the upper, inter-pole and lower pole intrarenal tributaries on each side. A renin ratio of > 1.5 between the main renal veins is considered significant. A ratio of < 1.3 between the contralateral renal vein and the infra-renal inferior vena cava supports this (McLaren and Roebuck 2003; Goonasekera et al. 2002).
Initial stabilization of the BP is undertaken using anti-hypertensive medications. Agents which block the renin-angiotensin-aldosterone system such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are contraindicated until critical main RAS or bilateral RA disease is excluded (Meyers et al. 2014). When the vascular disease is in third- and fourth-order branches, ACEi or ARB can be used to control the BP. However, the majority of children do not achieve normalization of their blood pressure despite treatment with up to six or seven different anti-hypertensive drugs (Lobeck et al. 2018; Tullus et al. 2008; Shroff et al. 2006).
Endovascular management of pediatric hypertension is indicated when blood-pressure control is inadequate or associated with significant adverse effects (Tullus et al. 2008). The goals of treatment are: restoration of renal perfusion, preservation of renal function, reduction in polypharmacy and temporizing hypertension in younger patients before surgical repair during/after puberty (Lobeck et al. 2018; Shroff et al. 2006).
Angioplasty is the most common intervention and can be performed even in small children in vessels with mild to severe stenoses. The renal artery proximal to the stenosis is used to guide angioplasty balloon size in view of the often seen post stenotic dilation distally (Fig. 1). If the balloon waist is not effaced during angioplasty balloon inflation a high-pressure balloon can then be used. The use of drug coated balloon angioplasty has been reported however there is little evidence to support their use at present (Agrawal et al. 2018). If vessels are completely occluded, they may be recanalized by angioplasty. This has been reported be successful children as small as 3.4 kg (Agrawal et al. 2018).
Cutting balloon angioplasty
Cutting balloon angioplasty has been used for high grade lesions resistant to conventional and high-pressure balloon angioplasty, long stenotic segments and restenosis (Srinivasan et al. 2010; Son JS 2015; Gumus et al. 2010; Alexander et al. 2017; Towbin et al. 2007). In the few series reporting cutting balloon angioplasty in children, in view of increased risk of complications such as dissection and renal artery aneurysm, cutting balloon diameter is recommended to be limited to no more than the normal vessel diameter in the incisional phase after which further dilation can be performed with a conventional balloon if required (Alexander et al. 2017; Towbin et al. 2007). Consideration should also be given to performing imaging of the arterial wall (for example by IVUS) to help place the cutting balloon in the safest position (Towbin et al. 2007).
Generally repeated angioplasty is considered more appropriate than stenting. Stent insertion is generally avoided in children because: stents themselves can act as a site of stenosis as the child grows, long term outcomes are unknown and in published series restenosis after stenting is significantly more common than after angioplasty (35.5% vs 17.4%) (Shroff et al. 2006; Kari et al. 2015). However, stent placement may be useful for severe or recurrent lesions, to manage iatrogenic dissection and vessels which show significant elastic recoil or restenosis after conventional or cutting balloon angioplasty (Shroff et al. 2006; Srinivasan et al. 2010; McLaren and Roebuck 2003). Surgical options should first be considered before placing a stent unless an emergent requirement. There are reports of the use of drug eluting and bioabsorbable stents in children, but this is not routine practice and there is insufficient data to support this practice (Agrawal et al. 2018; Arce-Santiago and Rodríguez-Cruz 2015).
Ethanol embolization of ischemic foci
Superselective ethanol embolization can be used to treat diseased segmental arteries which cannot be treated by angioplasty and where open reconstructive surgery is impossible (Teigen et al. 1992; Eliason et al. 2016). Ethanol causes severe, irreversible, endothelial injury. This results in infarction of the renin-producing ischemic parenchyma with less tissue loss than nephrectomy or partial nephrectomy. Coil embolization should be avoided because occlusion of medium-sized arteries will result in recruitment of collateral supply by the ischemic focus with persistent hypertension (Tullus et al. 2008).
Outcomes following endovascular treatment
Angioplasty (+/− stenting) for renovascular hypertension is beneficial in 48.5% to 100% of patients (Zhu et al. 2014; Shroff et al. 2006; Tyagi et al. 1997; Bayrak et al. 2008). Between 18% and 60% of patients are cured (defined as normal on no antihypertensive treatment) (Zhu et al. 2014; Lobeck et al. 2018; Shroff et al. 2006; Kari et al. 2015; Tyagi et al. 1997; Trautmann et al. 2017; Agrawal et al. 2018; Srinivasan et al. 2010; Alexander et al. 2017; Bayrak et al. 2008; Rumman et al. 2018; Colyer et al. 2014) and there is improvement (defined as BP <95th percentile while still requiring antihypertensive medications or diastolic BP reduced by more than 15% of pre-intervention) in 17–65% of patients (Zhu et al. 2014; Lobeck et al. 2018; Shroff et al. 2006; Kari et al. 2015; Tyagi et al. 1997; Trautmann et al. 2017; Agrawal et al. 2018; Srinivasan et al. 2010; Alexander et al. 2017; Bayrak et al. 2008; Rumman et al. 2018; Colyer et al. 2014).
Short-segment stenosis (< 10 mm) with residual stenosis < 10–20% after intervention have been reported to be associated with cure or clinical improvement (Zhu et al. 2014; Shroff et al. 2006; Tyagi et al. 1997; Srinivasan et al. 2010; Mali et al. 1987). The clinical result of angioplasty has not been found to be predicted by the degree of initial stenosis (Srinivasan et al. 2010) or patient age (Srinivasan et al. 2010; Alexander et al. 2017). The features predictive of outcomes are not consistent in all studies, for example one study of 28 children was unable to identify features of the diagnosis, stenosis degree or length or response to angioplasty that could predict, with statistical significance, the clinical outcome (Alexander et al. 2017).
Ostial lesions, which are more often seen in NF1 have been reported by some to be associated with better outcomes (Tyagi et al. 1997; Mali et al. 1987; Stanley et al. 1984) but not in all studies (Srinivasan et al. 2010). However, other studies in NF1 have found isolated lesions in the mid or distal part of the artery have a better outcome than lesions near the origin (Fossali et al. 2000). The presence of aneurysms, collateral vessels and mid- aortic narrowing do not predict the end result (Srinivasan et al. 2010).
The influence of underlying etiology of renovascular disease on outcomes is uncertain. Good outcomes have been reported in patients with NF1 without MAS, thought to be because these patients tend to have single, short-segment ostial stenosis and no intra-renal disease (Srinivasan et al. 2010). This conflicts with other published data that found decreased effectiveness for NF1 versus FMD and TA (Bayrak et al. 2008; Stanley et al. 1984; Fossali et al. 2000).
Despite findings that residual stenosis is predictive of poor blood pressure response, this does not always hold true. In one series 18 out of 78 treated children remained hypertensive despite radiologically adequate dilatation (Kari et al. 2015). On the other hand, a delayed response may be seen after angioplasty (Bayrak et al. 2008; Gardiner et al. 1988). The mechanism of the delayed response is thought to be related to smooth muscle spasm resulting in a false impression of residual narrowing on the post angioplasty angiogram or an increase in luminal diameter over time during arterial healing by retraction of fibrous bands (Bayrak et al. 2008; Gardiner et al. 1988).
Following angioplasty, restenosis is seen in 17 to 41% (Zhu et al. 2014; Lobeck et al. 2018; Kari et al. 2015; Tyagi et al. 1997; Bayrak et al. 2008; Colyer et al. 2014; Sharma et al. 1996; Sharma et al. 1998). Repeated angioplasty can be performed without increased risk (Shroff et al. 2006; Kari et al. 2015; Alexander et al. 2017). Reported time intervals between first and second procedures varies from 0.4 to 60 months (Kari et al. 2015). The arterial stenosis in children with renovascular hypertension is thought to be due to intimal hyperplasia (Stanley 2019). In children, non-stretch mechanisms such as tearing, flap formation, or dissection are the most common mechanisms of dilatation after balloon angioplasty (Ino et al. 1998) therefore repeated angioplasty may be advantageous in helping the vessels to remodel to a larger size.
In the long term, the success for angioplasty for FMD in children is less than that reported for adults (Srinivasan et al. 2010; Davies et al. 2008). This may be a result of smaller vessel diameter and a more pronounced response to growth factors in immature vasculature (Dillon 1997). This disease is thought to be one of fibrosis of the intima/media and not the classic medial hyperplasia described in adult females but there is limited pathological evidence for this (Stanley 2019). Other reasons for a lower response in children may be the higher rate of multiple stenosis especially those with MAS who present with widespread disease including bilateral RAS and intrarenal vascular pathology (Kari et al. 2015; Booth et al. 2002). In such cases, in the presence of significant intrarenal disease, successful treatment of main artery stenoses might fail to improve the BP (Kari et al. 2015).
Endovascular revascularization can improve renal function in addition to improving hypertension. Kari et al. (2015) reported a series of 30 children with abnormal 99 m-technetium-dimercapto-succinic acid scans (DMSA) pre angioplasty including reduced uptake or focal lesions which post angioplasty demonstrated DMSA normalization (i.e. equal uptake) in 6, improvement in 13, and static findings in 11.
In children with MAS, hypertension is often refractory to medical management despite the use of multiple medications (Zhu et al. 2014; König et al. 2006). Following angioplasty of the aorta and renal arteries +/− stenting, the change in systolic blood pressure is reported to be higher in children with mid-aortic syndrome and renal artery stenosis compared to those with isolated renal artery stenosis after intervention (Rumman et al. 2018). However, reports on long term outcomes following interventional management of mid-aortic syndrome are mixed. Some studies suggest that intervention is not very helpful with more than two thirds of children having persistent hypertension requiring long-term antihypertensive management (Rumman et al. 2018) whilst others report it very effective (König et al. 2006).
For mid-aortic syndrome, surgical interventions have been shown to require less re-intervention than endovascular interventions (Porras et al. 2013). Therefore, adopting a primary endovascular treatment strategy does require accepting that repeat interventions will be required. If planning a surgical approach, it may be preferable to wait until full adult growth and adult vascular size is reached however (Sethna et al. 2008). Adopting a primary endovascular treatment strategy may help achieve this growth.
Reported complication rates following endovascular treatment of hypertension are reported between 0% to 43% (Lobeck et al. 2018; Srinivasan et al. 2010; Alexander et al. 2017). Complications include contrast-induced nephropathy, arterial spasm, dissection (Fig. 5), delayed pseudoaneurysm (Fig. 6) formation and perforation. Parenchymal perfusion defects can occur with distal embolic phenomena post angioplasty (Fig. 7) or in situ thrombosis from prolonged guidewire lodgement in segmental vessels. Local dissection happens often and is expected, especially with the use of the cutting balloon, and as discussed above may be involved in the process of vascular remodelling and are not usually hemodynamically significant (Fig. 5) (Tullus et al. 2008). Procedure related deaths are rare. Kari et al. (2015) reported one procedure-related death in a series of 114 procedures. This was secondary to haemorrhage from a synthetic graft tear. In the event of arterial rupture if balloon reinflation or covered stent placement is not possible vascular surgery consultation should be readily available (Srinivasan et al. 2010; McLaren and Roebuck 2003). Following endovascular treatment the BP pressure may be labile and can increase the risk of stroke in children with concomitant cerebrovascular disease (Tullus et al. 2008), therefore assessment of the head and neck vessels should be considered prior to intervention (Sethna et al. 2008). Accelerated or worsening of hypertension following angioplasty has also been seen as rare complication (Srinivasan et al. 2010; Larar and Treves 1993).
In adults, a meta-analysis including 47 angioplasty studies (1616 patients) and 23 surgery studies (1014 patients) has shown the cure rate of surgery is slightly higher (54%) than that of angioplasty (36%) however this is at the cost of two and a half times higher major complication rate post-surgery compared to angioplasty (15% vs. 6%) (Trinquart et al. 2010). Similarly in a retrospective study including 381 patients, surgery for renal artery stenosis has been shown to have a higher complication rate and higher early and long term mortality (Alhadad et al. 2004). There is a paucity of similar data in the paediatric population.
Surgery is used infrequently as a primary treatment in children in many centres. Lobeck et al. (2018) reported that 10 patients in their series of 39 patients treated over 21 years underwent primary surgery. Reports from large series of open surgical interventions have high rates of cure of 70% (Stanley et al. 2006) and 82% (Lacombe 2011). Primary surgical intervention with a goal of managing renovascular disease in a single operation is not typically performed in view of the technical challenges in small children. There is some surgical viewpoint that angioplasty may alter the typical surgical approach, converting a primary renal arterial re-implantation into an aorto-renal bypass due to secondary fibrotic changes post angioplasty (Eliason et al. 2016). Studies in adult patients have shown that renal angioplasty has a shorter time to first re-do than surgical revascularization for renovascular disease (Alhadad et al. 2004). Given the established safety and success of endovascular intervention, at most institutions it remains the preferred treatment option.
Current literature supports an endovascular approach for investigation and management of renovascular hypertension in children. However, the outcome data presented here is derived from retrospective or prospective observational studies on relatively small patient numbers over long time periods with heterogeneity of reported cohorts in terms of etiology, response to medications, vascular involvement and endovascular treatments used (Zhu et al. 2014; Lobeck et al. 2018; Shroff et al. 2006; Kari et al. 2015; Agrawal et al. 2018; Srinivasan et al. 2010; Alexander et al. 2017; Bayrak et al. 2008; Rumman et al. 2018; Colyer et al. 2014; Mali et al. 1987; Stanley et al. 1984; Peco-Antić et al. 2016). The wide ranges of reported outcomes and paucity of information regarding factors predictive of outcomes relates to the nature of published studies. It is therefore difficult to develop clear guidelines for the diagnosis and management of renovascular hypertension in children. Prospective randomized studies are unlikely to play a significant role due to the rarity of the pathology and heterogeneity of the population.
In the future, data from national registries such as the United States Registry for FMD which was created in 2008 (Green et al. 2016) and dedicated working groups such as those formed at the First International Symposium on Pediatric Renovascular Hypertension in Ann Arbor, Michigan in November 2019, should help to develop more robust guidelines. At present there is consensus agreement that children with renovascular hypertension should be managed at centres with expertise in this area and the availability of multi-disciplinary care including, paediatric nephrologists, paediatric vascular surgeons and a paediatric interventional radiology team.
Availability of data and materials
99 m-technetium-dimercapto-succinic acid
Optical coherence tomography
Agrawal H, Moodie D, Qureshi AM, Acosta AA, Hernandez JA, Braun MC, Justino H (2018) Interventions in Children with Renovascular Hypertension: A 27-Year Retrospective Single-Center Experience. Congenit Heart Dis 13 (3):349–56. https://doi.org/10.1111/chd.12608
Alexander A, Richmond L, Geary D, Salle JLP, Amaral J, Connolly B (2017) Outcomes of percutaneous transluminal angioplasty for pediatric renovascular hypertension. J Pediatr Surg 52:395–399
Alhadad A, Ahle M, Ivancev K, Gottsäter A, Lindblad B (2004) Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularisation in renovascular disease--a retrospective comparison of results, complications, and mortality. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 27:151–156
Arce-Santiago M, Rodríguez-Cruz E (2015) Treatment of a recurrent renal artery stenosis and stent fracture using a drug eluting stent in a pediatric patient. CEN Case Rep 5:18–22
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis. Arthritis Rheum 33:1129–1134
Bartosh SM, Aronson AJ (1999) Childhood hypertension. An update on etiology, diagnosis, and treatment. Pediatr Clin N Am 46:235–252
Bayrak AH, Numan F, Cantaşdemir M, Baş A (2008) Percutaneous balloon angioplasty of renovascular hypertension in pediatric cases. Acta Chir Belg 108:708–714
Booth C, Preston R, Clark G, Reidy J (2002) Management of renal vascular disease in neurofibromatosis type 1 and the role of percutaneous transluminal angioplasty. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 17:1235–1240
Brun P, Kchouk H, Mouchet B, Baudouin V, Raynaud A, Loirat C et al (1997) Value of Doppler ultrasound for the diagnosis of renal artery stenosis in children. Pediatr Nephrol Berl Ger. 11:27–30
Brunner J, Feldman BM, Tyrrell PN, Kuemmerle-Deschner JB, Zimmerhackl LB, Gassner I et al (2010) Takayasu arteritis in children and adolescents. Rheumatology. 49:1806–1814
Castelli PK, Dillman JR, Kershaw DB, Khalatbari S, Stanley JC, Smith EA (2014) Renal sonography with Doppler for detecting suspected pediatric renin-mediated hypertension - is it adequate? Pediatr Radiol 44:42–49
Chhadia S, Cohn RA, Vural G, Donaldson JS (2013) Renal Doppler evaluation in the child with hypertension: a reasonable screening discriminator? Pediatr Radiol 43:1549–1556
Collins RT (2018) Cardiovascular disease in Williams syndrome. Curr Opin Pediatr 30:609–615
Colyer JH, Ratnayaka K, Slack MC, Kanter JP (2014) Renal artery stenosis in children: therapeutic percutaneous balloon and stent angioplasty. Pediatr Nephrol Berl Ger. 29:1067–1074
Conkbayir I, Yücesoy C, Edgüer T, Yanik B, Yaşar Ayaz U, Hekimoğlu B (2003) Doppler sonography in renal artery stenosis. An evaluation of intrarenal and extrarenal imaging parameters. Clin Imaging 27:256–260
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB (2008) The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 48:865–871
Delis KT, Gloviczki P (2005) Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther 17:187–203
Dillman JR, Smith EA, Coley BD (2017) Ultrasound imaging of renin-mediated hypertension. Pediatr Radiol 47:1116–1124
Dillon MJ (1997) The diagnosis of renovascular disease. Pediatr Nephrol Berl Ger. 11:366–372
Eliason JL, Coleman DM, Criado E, Kershaw DB, Blatt NB, Williams DM et al (2016) Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children. Pediatr Nephrol Berl Ger. 31:809–817
Forsey J, Dhandayuthapani G, Hamilton MCK, Martin RP, Tizard EJ, Ramanan AV (2011) Takayasu arteritis: key clinical factors for early diagnosis. Arch Dis Child - Educ Pract 96:176–182
Fossali E, Signorini E, Intermite RC, Casalini E, Lovaria A, Maninetti MM et al (2000) Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol Berl Ger. 14:806–810
Gardiner GA, Freedman AM, Shlansky-Goldberg R (1988) Percutaneous transluminal angioplasty: delayed response in neurofibromatosis. Radiology. 169:79–80
Goonasekera CDA, Shah V, Wade AM, Dillon MJ (2002) The usefulness of renal vein renin studies in hypertensive children: a 25-year experience. Pediatr Nephrol Berl Ger. 17:943–949
Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M et al (2019) First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med Lond Engl 24:164–189
Green R, Gu X, Kline-Rogers E, Froehlich J, Mace P, Gray B et al (2016) Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US registry. Pediatr Nephrol Berl Ger. 31:641–650
Gumus B, Cevik H, Vuran C, Omay O, Kocyigit OI, Turkoz R (2010) Cutting balloon angioplasty of bilateral renal artery stenosis due to Takayasu arteritis in a 5-year-old child with midterm follow-up. Cardiovasc Intervent Radiol 33:394–397
Ino T, Kishiro M, Okubo M, Akimoto K, Nishimoto K, Yabuta K et al (1998) Dilatation mechanism of balloon angioplasty in children: assessment by angiography and intravascular ultrasound. Cardiovasc Intervent Radiol 21:102–108
Kari JA, Roebuck DJ, McLaren CA, Davis M, Dillon MJ, Hamilton G et al (2015) Angioplasty for renovascular hypertension in 78 children. Arch Dis Child 100:474–478
Kchouk H, Brun P, Sentou Y, Raynaud A, Gaux JC, Loirat C (1997) Renal stenosis in hypertensive children. Doppler/arteriographic correlation. J Mal Vasc 22:86–90
König K, Gellermann J, Querfeld U, Schneider MBE (2006) Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases. Pediatr Nephrol Berl 21:663–671
Krumme B, Blum U, Schwertfeger E, Flügel P, Höllstin F, Schollmeyer P et al (1996) Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int 50:1288–1292
Kurian J, Epelman M, Darge K, Meyers K, Nijs E, Hellinger JC (2013) The role of CT angiography in the evaluation of pediatric renovascular hypertension. Pediatr Radiol 43:490–501 quiz 487–9
Lacombe M (2011) Surgical treatment of renovascular hypertension in children. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 41:770–777
Larar GN, Treves ST (1993) Accelerated renovascular hypertension following angioplasty. Assessment of therapy by Tc-99m DMSA imaging. Clin Nucl Med 18:278–280
Lie JT (1998) Vasculopathies of Neurofibromatosis type 1 (von Recklinghausen disease). Cardiovasc Pathol Off J Soc Cardiovasc Pathol 7:97–108
Lobeck IN, Alhajjat AM, Dupree P, Racadio JM, Mitsnefes MM, Karns R et al (2018) The management of pediatric renovascular hypertension: a single center experience and review of the literature. J Pediatr Surg 53:1825–1831
Louis R, Levy-Erez D, Cahill AM, Meyers KE (2018) Imaging studies in pediatric fibromuscular dysplasia (FMD): a single-center experience. Pediatr Nephrol Berl Ger. 33:1593–1599
Ma GMY, Dmytriw AA, Patel PA, Shkumat N, Krings T, Shroff MM, Muthusami P (2019) Quantitative Color-Coded Digital Subtraction Neuroangiography for Pediatric Arteriovenous Shunting Lesions. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery 35(12):2399–2403. https://doi.org/10.1007/s00381-019-04289-8.
Maehara A, Matsumura M, Ali ZA, Mintz GS, Stone GW (2017) IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal. JACC Cardiovasc Imaging 10:1487–1503
Mali WP, Puijlaert CB, Kouwenberg HJ, Klinge J, Donckerwolcke RA, Geijskes BG et al (1987) Percutaneous transluminal renal angioplasty in children and adolescents. Radiology. 165:391–394
McLaren CA, Roebuck DJ (2003) Interventional radiology for renovascular hypertension in children. Tech Vasc Interv Radiol 6:150–157
Meyers KE, Cahill AM, Sethna C (2014) Interventions for Pediatric Renovascular Hypertension. Curr Hypertens Rep 16 [cited 2016 Oct 9]. Available from: http://link.springer.com/10.1007/s11906-014-0422-3
Mizutani K, Itoh A, Sugioka K, Komatsu R, Naruko T, Yoshiyama M (2015) Intravascular findings of fibromuscular dysplasia on optical coherence tomography. J Cardiol Cases 12:39–42
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114:555–576
Onoue Y, Tsujita K, Hokimoto S, Kaikita K, Sugiyama S, Ogawa H (2011) In vivo intravascular ultrasound imaging of fibromuscular dysplastic region and intravascular pressure gradient-guided percutaneous transluminal renal angioplasty. J Cardiol Cases 4:e163–e167
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R et al (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806
Patel PA, Flouri D, Rennie A, Robertson F, Davies L, Ganesan V et al (2019) Quantifying the Intra-Operative Hemodynamic Effects of Glue Embolization in Vein of Galen Malformations. 2019 IEEE 16th Int Symp Biomed Imaging ISBI 2019, pp 754–758
Peco-Antić A, Stajić N, Krstić Z, Bogdanović R, Miloševski-Lomić G, Đukić M et al (2016) Associated extrarenal vascular diseases may complicate the treatment and outcome of renovascular hypertension. Acta Paediatr Oslo Nor 1992 105:e35–e41
Porras D, Stein DR, Ferguson MA, Chaudry G, Alomari A, Vakili K et al (2013) Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol 28:2023–2033
Roebuck D (2008) Childhood hypertension: what does the radiologist contribute? Pediatr Radiol 38:501–507
Rumman RK, Matsuda-Abedini M, Langlois V, Radhakrishnan S, Lorenzo AJ, Amaral J et al (2018) Management and outcomes of childhood renal artery stenosis and middle aortic syndrome. Am J Hypertens 31:687–695
Rumman RK, Nickel C, Matsuda-Abedini M, Lorenzo AJ, Langlois V, Radhakrishnan S et al (2015) Disease beyond the arch: a systematic review of middle aortic syndrome in childhood. Am J Hypertens 28:833–846
Sethna CB, Kaplan BS, Cahill AM, Velazquez OC, Meyers KEC (2008) Idiopathic mid-aortic syndrome in children. Pediatr Nephrol Berl Ger. 23:1135–1142
Shahdadpuri J, Frank R, Gauthier BG, Siegel DN, Trachtman H (2000) Yield of renal arteriography in the evaluation of pediatric hypertension. Pediatr Nephrol Berl Ger. 14:816–819
Sharma S, Gupta H, Saxena A, Kothari SS, Taneja K, Guleria S et al (1998) Results of renal angioplasty in nonspecific aortoarteritis (Takayasu disease). J Vasc Interv Radiol JVIR. 9:429–435
Sharma S, Thatai D, Saxena A, Kothari SS, Guleria S, Rajani M (1996) Renovascular hypertension resulting from nonspecific aortoarteritis in children: midterm results of percutaneous transluminal renal angioplasty and predictors of restenosis. Am J Roentgenol 166:157–162
Shroff R, Roebuck DJ, Gordon I, Davies R, Stephens S, Marks S et al (2006) Angioplasty for Renovascular hypertension in children: 20-year experience. PEDIATRICS. 118:268–275
Son JS (2015) Successful cutting balloon angioplasty in a child with resistant renal artery stenosis. BMC Res Notes 8 [cited 2018 Sep 10]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643536/
Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, Nijs E, Keller MS, Meyers K et al (2010) Angioplasty for renal artery stenosis in pediatric patients: an 11-year retrospective experience. J Vasc Interv Radiol JVIR 21:1672–1680
Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, Nijs E, Meyers K, Kaplan B et al (2011) Spectrum of renal findings in pediatric fibromuscular dysplasia and neurofibromatosis type 1. Pediatr Radiol 41:308–316
Stanley J (2019) A Histopathologic Review of Renal Artery Stenosis. In: First International Symposium on Pediatric Renovascular Hypertension, Ann Arbor, Michigan
Stanley JC, Criado E, Eliason JL, Upchurch GR, Berguer R, Rectenwald JE (2008) Abdominal aortic coarctation: surgical treatment of 53 patients with a thoracoabdominal bypass, patch aortoplasty, or interposition aortoaortic graft. J Vasc Surg 48:1073–1082
Stanley JC, Criado E, Upchurch GR, Brophy PD, Cho KJ, Rectenwald JE et al (2006) Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg 44:1219–1228 discussion 1228-1229
Stanley P, Hieshima G, Mehringer M (1984) Percutaneous transluminal angioplasty for pediatric renovascular hypertension. Radiology. 153:101–104
Teigen CL, Mitchell SE, Venbrux AC, Christenson MJ, McLean RH (1992) Segmental renal artery embolization for treatment of pediatric renovascular hypertension. J Vasc Interv Radiol JVIR. 3:111–117
Towbin RB, Pelchovitz DJ, Baskin KM, Cahill AM, Roebuck DJ, McClaren CA (2007) Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol 18:663–669
Trautmann A, Roebuck DJ, McLaren CA, Brennan E, Marks SD, Tullus K (2017) Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension. Pediatr Nephrol Berl Ger 32:495–502
Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin P-F (2010) Efficacy of revascularization for renal artery stenosis caused by Fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 56:525–532
Tullus K (2011) Renal artery stenosis: is angiography still the gold standard in 2011? Pediatr Nephrol Berl Ger. 26:833–837
Tullus K (2018) To screen or not to screen: for high blood pressure. Pediatr Nephrol Berl Ger. 33:81–82
Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD et al (2008) Renovascular hypertension in children. Lancet Lond Engl 371:1453–1463
Tullus K, Roebuck DJ (2018) Renovascular hypertension in small children-is it Takayasu arteritis or fibromuscular dysplasia? J Am Soc Hypertens JASH 12:506–508
Tullus K, Roebuck DJ, McLaren CA, Marks SD (2010) Imaging in the evaluation of renovascular disease. Pediatr Nephrol 25:1049–1056
Tummolo A, Marks SD, Stadermann M, Roebuck DJ, McLaren CA, Hamilton G et al (2009) Mid-aortic syndrome: long-term outcome of 36 children. Pediatr Nephrol Berl Ger. 24:2225–2232
Tyagi S, Kaul UA, Satsangi DK, Arora R (1997) Percutaneous transluminal angioplasty for renovascular hypertension in children: initial and long-term results. Pediatrics. 99:44–49
Vijayvergiya R, Kanabar K, Krishnappa D, Kasinadhuni G, Sharma A, Akasaka T (2019) Optical coherence tomography in varying aetiologies of renal artery stenosis: a case series. Eur Heart J Case Rep 3:ytz068 Brown RA, Moutiris J, Mukherjee R, Green P, editors
Vo NJ, Hammelman BD, Racadio JM, Strife CF, Johnson ND, Racadio JM (2006) Anatomic distribution of renal artery stenosis in children: implications for imaging. Pediatr Radiol 36:1032–1036
Zhu G, He F, Gu Y, Yu H, Chen B, Hu Z et al (2014) Angioplasty for pediatric renovascular hypertension: a 13-year experience. Diagn Interv Radiol 20:285–292
Ethics approval and consent to participate
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Patel, P.A., Cahill, A.M. Renovascular hypertension in children. CVIR Endovasc 4, 10 (2021). https://doi.org/10.1186/s42155-020-00176-5